Protein acetylation, especially histone acetylation, is the subject of both research and clinical investigation. At least four small-molecule histone deacetylase inhibitors are currently in clinical trials for the treatment of cancer. These and other inhibitors also affect microtubule acetylation. A multidimensional, chemical genetic screen of 7,392 small molecules was used to discover ''tubacin,'' which inhibits ␣-tubulin deacetylation in mammalian cells. Tubacin does not affect the level of histone acetylation, gene-expression patterns, or cell-cycle progression. We provide evidence that class II histone deacetylase 6 (HDAC6) is the intracellular target of tubacin. Only one of the two catalytic domains of HDAC6 possesses tubulin deacetylase activity, and only this domain is bound by tubacin. Tubacin treatment did not affect the stability of microtubules but did decrease cell motility. HDAC6 overexpression disrupted the localization of p58, a protein that mediates binding of Golgi elements to microtubules. Our results highlight the role of ␣-tubulin acetylation in mediating the localization of microtubuleassociated proteins. They also suggest that small molecules that selectively inhibit HDAC6-mediated ␣-tubulin deacetylation, a first example of which is tubacin, might have therapeutic applications as antimetastatic and antiangiogenic agents.

New catalytic synthetic methods in organic chemistry that satisfy increasingly stringent environmental constraints are in great demand by the pharmaceutical and chemical industries. In addition, novel catalytic procedures are necessary to produce the emerging classes of organic compounds that are becoming the targets of molecular and biomedical research. Enzyme-catalysed chemical transformations are now widely recognized as practical alternatives to traditional (non-biological) organic synthesis, and as convenient solutions to certain intractable synthetic problems.

No abstract

Azides have proven to be useful precursors to amines in organic syntheses. This report describes an improvement of the diazotransfer reaction and the first example of a regioselective azide reduction of compounds containing multiple azides. The use of a specific ratio of solvents and zinc chloride as a catalyst resulted in a more efficient diazotransfer reaction capable of delivering >90% conversion per amine with shorter reaction times than those previously reported. Azides can be reduced with good regioselectivity in moderate yields by a modification of the Staudinger reaction using trimethylphosphine at low temperatures. Electronic factors determine the selectivity for azide reduction, and the reaction is predictable by NMR analysis of the starting material. Several examples for the diazotransfer and regioselective azide reduction reactions are given, and a mechanistic hypothesis for both is proposed.